THE LIVINGSTON GROUP, LLC

Lobbying for INNOVATIVE VACCINE TECHNOLOGIES · Bio tech company

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 10, 2025

Income

$30,000.00

What the client paid this registrant for the period.

Client based in

Utah

Lobbying activity 2

Medical/Disease Research/Clinical Labs

FY2026 appropriations for the development of a synthetic vaccine

Budget/Appropriations

FY2026 appropriations for the development of a synthetic vaccine

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.